APA (7th ed.) Citation

Grasse, S., & Sültmann, H. (2018). Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance. Genome medicine, 10, . https://doi.org/10.1186/s13073-018-0562-1

Chicago Style (17th ed.) Citation

Grasse, Sabrina, and Holger Sültmann. "Epigenomic Profiling of Non-small Cell Lung Cancer Xenografts Uncover LRP12 DNA Methylation as Predictive Biomarker for Carboplatin Resistance." Genome Medicine 10 (2018). https://doi.org/10.1186/s13073-018-0562-1.

MLA (9th ed.) Citation

Grasse, Sabrina, and Holger Sültmann. "Epigenomic Profiling of Non-small Cell Lung Cancer Xenografts Uncover LRP12 DNA Methylation as Predictive Biomarker for Carboplatin Resistance." Genome Medicine, vol. 10, 2018, https://doi.org/10.1186/s13073-018-0562-1.